Home/Filings/4/0001683168-24-006377
4//SEC Filing

Infarinato Robert M. 4

Accession 0001683168-24-006377

CIK 0001533040other

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 3:00 PM ET

Size

5.1 KB

Accession

0001683168-24-006377

Insider Transaction Report

Form 4
Period: 2024-09-11
Infarinato Robert M.
VP, Chief Financial Officer
Transactions
  • Award

    Common Stock, $0.0001 Par Value

    2024-09-11+3,00011,000 total
Footnotes (2)
  • [F1]Represents shares underlying a restricted stock unit, which shares will vest in one year on the first anniversary.
  • [F2]Includes shares of common stock underlying unvested restricted stock units.

Documents

1 file

Issuer

Phio Pharmaceuticals Corp.

CIK 0001533040

Entity typeother

Related Parties

1
  • filerCIK 0002032518

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 3:00 PM ET
Size
5.1 KB